British Journal of CancerKornek GV, Hejna M, Haider K, Kwasny W, Raderer M, Meghdadi S, Burger D, Schnee- weiss B, Depisch D, Scheithauer W: Effective treatment of advanced breast cancer with vi- norelbine, mitomycin C plus human granulo- cyte colony-stimulating factor. Br J Cancer...
To more effectively treat patients with triple negative breast cancer (TNBC), a greater understanding of the disease must first be obtained, said Angela DeMichele, MD, professor of medicine and epidemiology, breast cancer oncologist, University of Pennsylvania. In an interview withTargeted Oncol...
The in vitro efficacy of fVII-tPDT was 12-fold stronger than that of ntPDT for MCF-7/MDR cancer cells, and the mechanism of action involved induction of apoptosis and necrosis. Moreover, fVII-tPDT was effective and safe for the treatment of chemoresistant breast tumours in the nude mouse...
therapy, advances in chemotherapy and a shift in the clinical philosophy of breast cancer care from maximum tolerable treatment to minimum effective therapy... R Kramer - 《Breast Cancer Research》 被引量: 5发表: 2003年 From the maximum tolerable to the minimum effective treatment: The Umberto...
Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro- apoptotic changes. EurJ Cancer. 2000; 36(7): 845- 851.Cameron DA,Keen JC,Dixon JM,et al.Effective tamoxifen therapy of breast cancer involves both antiproliferative and pro-apoptotic changes. European Journal of ...
Ovarian suppression for breast cancer: an effective treatment in search of a home. Clinical Oncology Krop IE,Winer EP. Ovarian suppression for breast cancer: an effective treatment in search of a home. J Clin Oncol 2005;23(25):1-3... EP Krop IEWiner - 《Journal of Clinical Oncology》 被...
There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two f
A breast cancer test has been found that helps doctors make treatment decisions for some breast cancer patients, following research carried out at Queen Mary University of London and funded by Cancer Research UK.
Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status. Discusses the effectiveness of using Tamoxifen as an adjuvant treatment for BRCA1-related breast cancer. Ability of Tamoxifen in preventing the development... Foulkes,D William,Goff...
In this review, we summarize the methods of functional modification and application of TDN in cancer treatment. Also, we discuss the pressing questions that should be targeted to increase the applicability of TDN in the future. Graphical Abstract...